Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
Keiya Uriu, Jumpei Ito, Jiří Zahradník, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 280-281
Open Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

Promoting aged care COVID-19 and influenza vaccination through education of Australian residential aged care staff: A mixed methods project evaluation
Isaac Tranter, Deborah A. Judd, Mark Stickley, et al.
Vaccine (2025) Vol. 48, pp. 126742-126742
Closed Access
Virological characteristics of the SARS-CoV-2 XBB.1.5 variant
Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1
Ryuta Uraki, Mutsumi Ito, Maki Kiso, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 5, pp. 525-526
Open Access | Times Cited: 16
Virological characteristics of the SARS-CoV-2 Omicron EG.5.1 variant
Shuhei Tsujino, Sayaka Deguchi, Tomo Nomai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 16
Computational Protein Design for COVID-19 Research and Emerging Therapeutics
Parismita Kalita, Timir Tripathi, Aditya K. Padhi
ACS Central Science (2023) Vol. 9, Iss. 4, pp. 602-613
Open Access | Times Cited: 15
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
Saya Moriyama, Yuki Anraku, Shunta Taminishi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Targeted amplicon sequencing of wastewater samples for detecting SARS-CoV-2 variants with high sensitivity and resolution
Miho Kuroiwa, Yoshinari Gahara, Hirohito Kato, et al.
The Science of The Total Environment (2023) Vol. 893, pp. 164766-164766
Open Access | Times Cited: 14
Spatiotemporal dynamics and epidemiological impact of SARS-CoV-2 XBB lineage dissemination in Brazil in 2023
Ighor Arantes, Marcelo Ferreira da Costa Gomes, Kimihito Ito, et al.
Microbiology Spectrum (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 5
Role of SARS-CoV-2 mutations in the evolution of the COVID-19 pandemic
Philippe Colson, Hervé Chaudet, Jérémy Delerce, et al.
Journal of Infection (2024) Vol. 88, Iss. 5, pp. 106150-106150
Open Access | Times Cited: 5
Neutralizing antibodies after the third COVID-19 vaccination in healthcare workers with or without breakthrough infection
Arttu Reinholm, Sari Maljanen, Pinja Jalkanen, et al.
Communications Medicine (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 4
A Protein Language Model for Exploring Viral Fitness Landscapes
Jumpei Ito, Adam Strange, Wei Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
SARS-CoV-2 Omicron XBB lineage spike structures, conformations, antigenicity, and receptor recognition
Qianyi E. Zhang, Jared Lindenberger, Ruth Parsons, et al.
Molecular Cell (2024) Vol. 84, Iss. 14, pp. 2747-2764.e7
Open Access | Times Cited: 4
Bivalent booster effectiveness against severe COVID-19 outcomes in Finland, September 2022 – March 2023
Eero Poukka, Hanna Nohynek, Sirkka Goebeler, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 13
Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against Omicron subvariants including EG.5
Yu Kaku, Yusuke Kosugi, Keiya Uriu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 12
The Omicron XBB.1 Variant and Its Descendants: Genomic Mutations, Rapid Dissemination and Notable Characteristics
Raffaele Giancotti, Ugo Lomoio, Barbara Puccio, et al.
Biology (2024) Vol. 13, Iss. 2, pp. 90-90
Open Access | Times Cited: 3
Akaluc bioluminescence offers superior sensitivity to track in vivo dynamics of SARS-CoV-2 infection
Tomokazu Tamura, Hayato Ito, Shiho Torii, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109647-109647
Open Access | Times Cited: 3
JN.1 and the ongoing battle: unpacking the characteristics of a new dominant COVID-19 variant
Reza Eshraghi, Ashkan Bahrami, Motahare Karimi Houyeh, et al.
Pathogens and Global Health (2024) Vol. 118, Iss. 6, pp. 453-458
Closed Access | Times Cited: 3
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Yue Yang, Yidan Luo, Chenbo Zhang, et al.
ACS Omega (2024) Vol. 9, Iss. 32, pp. 34196-34219
Open Access | Times Cited: 3
Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Zhencui Li, Pei Hu, Qu Lin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
A quadri-fluorescence SARS-CoV-2 pseudovirus system for efficient antigenic characterization of multiple circulating variants
Jijing Chen, Zehong Huang, Jin Xiao, et al.
Cell Reports Methods (2024) Vol. 4, Iss. 9, pp. 100856-100856
Open Access | Times Cited: 3
Deciphering the free energy landscapes of SARS-CoV-2 wild type and Omicron variant interacting with human ACE2
Pham Dang Lan, Daniel A. Nissley, Edward P. O’Brien, et al.
The Journal of Chemical Physics (2024) Vol. 160, Iss. 5
Closed Access | Times Cited: 3
Neutralization of SARS-CoV-2 BQ.1.1 and XBB.1.5 by Breakthrough Infection Sera from Previous and Current Waves in China
Xun Wang, Shuai Jiang, Shujun Jiang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants
Zongming Liu, Jiaxuan Li, Shanshan Pei, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 9
Rapid Detection of SARS-CoV-2 RNA Using Reverse Transcription Recombinase Polymerase Amplification (RT-RPA) with Lateral Flow for N-Protein Gene and Variant-Specific Deletion–Insertion Mutation in S-Protein Gene
J. L. Granda, Mónica J. Pajuelo, Michiko Okamoto, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1254-1254
Open Access | Times Cited: 8
Impact of Imprinted Immunity Induced by mRNA Vaccination in an Experimental Animal Model
Shigeru Fujita, Keiya Uriu, Lin Pan, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 8, pp. 1060-1065
Open Access | Times Cited: 8

Scroll to top